Dr. Elliot Roth, MD
Claim this profileStudies Coronavirus
Studies Mental Fatigue
1 reported clinical trial
1 drug studied
Clinical Trials Elliot Roth, MD is currently running
More about Elliot Roth, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Elliot Roth, MD has experience with
- Attention Training
Breakdown of trials Elliot Roth, MD has run
Coronavirus
Mental Fatigue
Post-COVID Syndrome
Long COVID Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elliot Roth, MD specialize in?
Elliot Roth, MD focuses on Coronavirus and Mental Fatigue. In particular, much of their work with Coronavirus has involved treating patients, or patients who are undergoing treatment.
Is Elliot Roth, MD currently recruiting for clinical trials?
Yes, Elliot Roth, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Elliot Roth, MD has studied deeply?
Yes, Elliot Roth, MD has studied treatments such as Attention Training.
What is the best way to schedule an appointment with Elliot Roth, MD?
Apply for one of the trials that Elliot Roth, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.